COMMUNIQUÉS West-GlobeNewswire

-
Pluristem Concludes Positive Meeting with FDA on Development Plan for Acute Radiation Syndrome
03/01/2019 -
Cabaletta Bio to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019 -
Ultragenyx to Present at J.P. Morgan Healthcare Conference
03/01/2019 -
Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
03/01/2019 -
Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence
03/01/2019 -
Matinas BioPharma Appoints Keith A. Kucinski, CPA, MBA as Chief Financial Officer
03/01/2019 -
United Soybean Board Awards Grant to Amfora to Increase the Protein Content of U.S. Soy
03/01/2019 -
Obalon Announces Promotion of Amy VandenBerg to Chief Clinical & Regulatory Affairs Officer
03/01/2019 -
Allscripts to present at the J.P. Morgan 2019 Healthcare Conference
03/01/2019 -
EDAP TMS SA : John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One® Technology for Prostate Tissue Ablation
03/01/2019 -
Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019 -
Intra-Cellular Therapies to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019 -
Hemostemix Announces Two Additional Sites Enrolled in Phase II Clinical Trial
03/01/2019 -
Samumed Granted Orphan Drug Designation for SM08502 for the Treatment of Pancreatic Cancer
03/01/2019 -
Replimune Highlights Company Progress and Expected 2019 Milestones Ahead of Presentation at the 37th Annual JPMorgan Healthcare Conference
03/01/2019 -
Fulgent Genetics and Columbia University Irving Medical Center Partner on Expanded Carrier Screening
03/01/2019 -
Aduro Biotech to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019 -
Wave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot Program
03/01/2019 -
Jounce Therapeutics Completed Enrollment in First Cohort of Phase 1 Clinical Trial with its PD-1 Inhibitor, JTX-4014
03/01/2019
Pages